Pharmaids Pharmaceuticals Hits 52-Week High, Outperforms Sector and Sensex

Nov 11 2024 09:39 AM IST
share
Share Via
Pharmaids Pharmaceuticals, a microcap company in the pharmaceuticals and drugs industry, has reached a new milestone with its stock price hitting a 52-week high of Rs.79.34 on November 11, 2024. Despite being rated as a 'Strong Sell' by MarketsMojo, the company has outperformed the sector by 4.75% and has been on a consecutive gain streak for the past 9 days. It is currently trading higher than its moving averages and has shown a significant 1-year performance of 80.07%, highlighting its strong potential for growth.


Pharmaids Pharmaceuticals, a microcap company in the pharmaceuticals and drugs industry, has recently reached a new milestone. On November 11, 2024, the company's stock price hit a 52-week high of Rs.79.34. This news has caught the attention of investors and market analysts alike.

According to MarketsMOJO, a leading stock market analysis platform, the stock call for Pharmaids Pharmaceuticals is currently a 'Strong Sell'. However, the company's recent performance has been impressive. It has outperformed the sector by 4.75% and has been on a consecutive gain streak for the past 9 days, with a remarkable 130.3% increase in returns during this period.

The stock opened today with a gain of 4.99% and touched an intraday high of Rs.79.34. It has been trading at this price since then, indicating a strong hold in the market. Additionally, Pharmaids Pharmaceuticals is currently trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, which is a positive sign for investors.

In comparison to the Sensex, Pharmaids Pharmaceuticals has shown a significant 1-year performance of 80.07%, while the Sensex has only recorded a 22.44% increase. This further highlights the company's strong performance and potential for growth.

Pharmaids Pharmaceuticals has been making waves in the pharmaceutical industry with its consistent growth and impressive financial results. With its recent achievement of reaching a 52-week high, the company is poised for further success in the future.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News